Role of Ezetimibe in Combination with Statins(Simvastatin and Atorvastatin) in Controlling Dyslipidemia
Cardiovascular risk is independently increased by plasma lipids abnormalities (low- density and high density lipoprotein -cholesterol and triglycerides). Most patients have more than one lipid abnormality. Combination therapy with lipid-modifying agents could offer an important therapeuti...
Main Authors: | Falah H.Al-Malki, Shatha H. Ali, Gamal A.Abdulbari |
---|---|
Format: | Article |
Language: | English |
Published: |
College of Pharmacy University of Baghdad
2017-03-01
|
Series: | Iraqi Journal of Pharmaceutical Sciences |
Online Access: | https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/547 |
Similar Items
-
Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy
by: Foody JM, et al.
Published: (2013-11-01) -
Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia
by: Lahey Karen A, et al.
Published: (2009-12-01) -
Complementary therapy to target LDL cholesterol: the role of the ezetimibe/simvastatin combination
by: Ryan C Neal, et al.
Published: (2006-03-01) -
Efficacy of Ezetimibe/Simvastatin (10/10 mg) Versus High Dose Statin in Dyslipidemia Patients: A Meta-Analysis of Randomized Controlled Trials
by: Gaoming YANG, et al.
Published: (2019-07-01) -
Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin
by: Masadeh Majed, et al.
Published: (2012-05-01)